Administration of scutellarein in mice suppressed atopic dermatitis induced by 2,4-dinitrofluorobenzene and pruritus induced by carvacrol and alleviated epidermal hyperplasia and skin inflammatory response, but showed no benefit in TRPV3-knockout mice in the carvacrol model. This evidence concerns the gene TRPV3 and atopic eczema.